Bionano Genomics, Inc.
Bionano Genomics, Inc., a leading player in the genomics industry, is headquartered in the United States, with significant operations across North America and Europe. Founded in 2003, the company has made remarkable strides in genomic analysis, particularly through its innovative optical genome mapping technology. This unique approach allows researchers to visualise and analyse complex genomic structures with unprecedented clarity. Bionano's flagship product, the Saphyr system, stands out for its ability to detect structural variations in DNA that traditional sequencing methods often miss. This capability positions Bionano as a vital resource for researchers in oncology, genetic disorders, and other fields requiring detailed genomic insights. With a strong market presence and a commitment to advancing genomic research, Bionano Genomics continues to drive innovation and enhance the understanding of genetic diseases.
DitchCarbon Score
How does Bionano Genomics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Bionano Genomics, Inc.'s score of 23 is lower than 65% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Bionano Genomics, Inc.'s reported carbon emissions
Bionano Genomics, Inc., headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year, nor does it report specific reduction targets or initiatives related to climate commitments. As of now, there are no emissions figures, such as Scope 1, 2, or 3 emissions, nor any details on science-based targets or climate pledges. The absence of this data suggests that Bionano Genomics may still be in the early stages of developing a comprehensive climate strategy or reporting framework. Without specific emissions data or commitments, it is challenging to assess their environmental impact or sustainability efforts within the genomics industry.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Bionano Genomics, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
